Syndax Pharmaceuticals Inc.
SNDX | NASDAQ
$18.18
+$0.11 (+0.61%)
Sep 22, 2026, 11:24 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 134.93M | 154.08M | 295.39M | 74.36M | 221.97M | 115.24M |
Short-Term Investments | 278.76M | 428.83M | 282.19M | 410.04M | 224.87M | 177.82M |
Long-Term Investments | n/a | 119.52M | 29.83M | 5.47M | n/a | n/a |
Other Long-Term Assets | 102K | 217K | 680K | 922K | n/a | 1.27M |
Receivables | 70.29M | 13.87M | 1.23M | 4.06M | 429K | 175K |
Inventory | 32.75M | 366K | n/a | n/a | n/a | n/a |
Other Current Assets | 1.22M | -2.02M | 63K | 117K | 265K | 456K |
Total Current Assets | 528.08M | 603.06M | 580.88M | 489.79M | 448.4M | 298.86M |
Property-Plant & Equipment | 1.52M | 2.02M | 1.5M | 1.06M | 1.26M | 482K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.63M | 121.76M | 32M | 7.45M | 1.26M | 1.75M |
Total Assets | 529.71M | 724.82M | 612.88M | 497.24M | 449.66M | 300.61M |
Account Payables | 16.58M | 11.63M | 9.96M | 4.35M | 5.67M | 3.51M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 1.52M |
Short-Term Debt | n/a | 12.12M | n/a | n/a | n/a | 2.29M |
Other Current Liabilities | 103.06M | 15.75M | 35.92M | 6.55M | 6.23M | 3.74M |
Total Current Liabilities | 120.12M | 103.55M | 58.1M | 29.07M | 20.68M | 18.87M |
Long-Term Debt | 344.96M | 331.57M | n/a | n/a | 19.9M | 17.83M |
Other Long-Term Liabilities | -1.05M | n/a | n/a | n/a | n/a | 1K |
Total Long-Term Liabilities | 344.96M | 333.14M | 588K | 722K | 20.61M | 29.55M |
Total Liabilities | 465.08M | 436.69M | 58.68M | 29.79M | 41.29M | 48.43M |
Total Debt | 346.48M | 345.74M | 1.64M | 1.16M | 20.97M | 20.54M |
Book Value | 64.63M | 288.12M | 554.2M | 467.45M | 408.37M | 252.19M |
Book Value Per Share | 0.75 | 3.37 | 7.88 | 7.69 | 7.84 | 6.11 |
Common Stock | 9K | 9K | 8K | 7K | 6K | 5K |
Retained Earnings | -1.51B | -1.22B | -902.4M | -693.04M | -543.7M | -568.63M |
Comprehensive Income | 452K | 163K | 218K | -806K | 45K | -4K |
Shareholders Equity | 64.63M | 288.12M | 554.2M | 467.45M | 408.37M | 252.19M |
Total Investments | 278.76M | 548.35M | 312.02M | 415.51M | 224.87M | 177.82M |
Add to Watchlist
Select watchlists to add or remove SNDX